XML 17 R4.htm IDEA: XBRL DOCUMENT v3.23.1
Consolidated Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Revenue $ 2,719 $ 3,555
Cost of goods sold (686) (671)
Gross profit 2,033 2,884
Operating expenses:    
Research and development expenses 18,583 13,778
Selling, general and administrative expenses 17,303 13,637
Total operating expenses 35,886 27,415
Operating loss (33,853) (24,531)
Interest expense, net (2,685) (1,186)
Other income 30 68
Net loss (36,508) (25,649)
Other comprehensive (loss) income:    
Foreign currency translation adjustments 101 122
Total other comprehensive loss $ (36,407) $ (25,527)
Common share data:    
Basic loss per common share* $ (4.12) $ (3.59)
Diluted loss per common share* $ (4.12) $ (3.59)
Weighted average number of basic shares outstanding* 8,864,615 7,145,754
Weighted average number of diluted shares outstanding* 8,864,615 7,145,754
Product Revenue [Member]    
Revenue $ 2,548 $ 1,300
Other Revenue [Member]    
Revenue $ 171 $ 2,255